Sanofi is trading at $41.16, up 4.03%, amid a healthcare-sector rally, the clearest available context.
- The sector gained 2.12% as investors rotated from technology stocks toward healthcare.
- No Sanofi-specific explanation for the October 20 move appeared in searched headlines; Schwab listed none for that date.
- Leerink Partners reaffirmed its Buy rating on October 19, but that report did not establish the cause of today’s rise.